Skip to content

Para Aortic Lymphadenectomy : Always ?

Assesment of Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer, When no Pathologic Pelvic Lymph Node on PET/CT: Retrospective Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04392895
Acronym
PALA
Enrollment
160
Registered
2020-05-19
Start date
2017-01-01
Completion date
2020-06-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Locally advanced cervical cancer, more than IB3 stage FIGO 2018, Para aortic lymphadenectomy, Laparoscopy, PET/CT

Brief summary

Cervical cancer affects more than 3000 new cases per year in France. The treatment of stage IB3 to IVA cervical cancer is based on concomitant radio-chemotherapy. The irradiation volumes are based, according to current recommendations, on imaging examinations and / or on the results of a laparoscopic Para-aortic lymphadenectomy (PAL). There is some risk of false negatif with the PET/CT. For this reason, most of the time, PAL is offered when there is no pathological paraaortic lymph node on PET/CT. The investigators suppose that this staging surgery could be avoid when no pathological pelvic nodes are identified on PET/CT. The investigators use a retrospective study, to analyse histological report of systematic PAL, comparing to results of pre-operative PET/CT.

Interventions

PROCEDUREPara Aortic Lymphadenectomy (PAL) by laparoscopy

Para Aortic Lymphadenectomy (PAL) by laparoscopy

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients with : * locally advanced cervical cancer, * who undergone PAL * with pre operative PET CT, between January 2015 and december 2019

Exclusion criteria

\- patients aged under 18

Design outcomes

Primary

MeasureTime frameDescription
negative predictive value of PET/CT on para aortic nodes when no pathological pelvic nodes.1 daynegative predictive value of PET/CT on para aortic nodes when no pathological pelvic nodes. The intraoperative 3D optical scan gives the tumor localization obtained by radioguided occult lesion localization thanks to pen marking left by the surgeon. The comparison is done by superimposing both acquisitions.

Secondary

MeasureTime frameDescription
morbidity of PAL1 daymorbidity of PAL

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026